NCT00998465

Brief Summary

The purpose of this study is to evaluate the effect of high vs. low sodium intake on blood pressure and system hemodynamics in patients with morbid obesity and to evaluate the impact of laparoscopic gastric bypass on blood pressure, salt sensitivity and body composition in morbidly obese patients. Furthermore, we wants to describe the hemodynamic mechanisms involved in the amelioration of blood pressure during long-term weight loss.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2009

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 19, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 20, 2009

Completed
12 days until next milestone

Study Start

First participant enrolled

November 1, 2009

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2013

Completed
Last Updated

March 20, 2013

Status Verified

March 1, 2013

Enrollment Period

3.1 years

First QC Date

October 19, 2009

Last Update Submit

March 19, 2013

Conditions

Keywords

ObesityHypertensionSalt sensitivityLaparoscopic gastric bypassBariatric surgery

Outcome Measures

Primary Outcomes (1)

  • Sodium induced change in 24-hour blood pressure before and one year after laparoscopic gastric bypass.

    One year

Secondary Outcomes (4)

  • Echocardiography: Dimensions, systolic and diastolic function before and one year after laparoscopic gastric bypass

    One year

  • Non-invasive hemodynamic measurements (inert gas rebreathing) before and one year after laparoscopic gastric bypass

    One year

  • Body composition: Dexa-scan, plasma volume and extracellular volume before and one year after laparoscopic gastric bypass

    One year

  • Blood samples: MR-proANP, p-glucose, p-insulin

    One year

Study Arms (3)

Obese, hypertension

Obese patients with hypertension and a body mass index 40-50 kg/m2

Other: 24-hour blood pressureOther: EchocardiographyOther: Inert gas rebreathingRadiation: Dexa-scanRadiation: Plasma volumeRadiation: Glomerular filtration rate (GFR)Other: Blood samplesOther: Urine analysesDietary Supplement: Diets with low and high sodium content

Control

Control subjects without hypertension and body mass index \< 30 kg/m2

Other: 24-hour blood pressureOther: EchocardiographyOther: Inert gas rebreathingRadiation: Dexa-scanRadiation: Plasma volumeRadiation: Glomerular filtration rate (GFR)Other: Blood samplesOther: Urine analysesDietary Supplement: Diets with low and high sodium content

Obese, normotension

Obese patients without hypertension and a BMI between 40-50 kg/m2

Other: 24-hour blood pressureOther: EchocardiographyOther: Inert gas rebreathingRadiation: Dexa-scanRadiation: Plasma volumeRadiation: Glomerular filtration rate (GFR)Other: Blood samplesOther: Urine analysesDietary Supplement: Diets with low and high sodium content

Interventions

Blood pressure is measured every 15 minutes in the daytime and every 30 minutes at night

ControlObese, hypertensionObese, normotension

Standard 2-D and m-mode echocardiography with determination of dimensions, systolic, and diastolic function.

ControlObese, hypertensionObese, normotension

Cardiac output, stroke volume and total peripheral resistance are tested at rest and during exercise (bicycle ergometer) using non-invasive equipment (inert gas rebreathing - Innocor)

ControlObese, hypertensionObese, normotension
Dexa-scanRADIATION

Fat mass and fat free mass is determined with a whole body Dexa scan, and bone mineral density is tested with Dexa-scans of the lumbar spine and proximal femur.

ControlObese, hypertensionObese, normotension
Plasma volumeRADIATION

The test is performed using 5 MBq technetium-labeled albumine (99mTc-albumine - Vasculosis) with several postinjection samples for accurate zero-time extrapolation.

ControlObese, hypertensionObese, normotension

GFR and ECV are determined following injection of 3,7 MBq 51Cr-EDTA and postinjection samples three-four hours after injection.

ControlObese, hypertensionObese, normotension

p-glucose, p-insulin, NT-proBNP, hemoglobin, potassium, sodium, creatinine, albumine

ControlObese, hypertensionObese, normotension

24-hour urine collections with determination of u-sodium, u-potassium and u-creatinine.

ControlObese, hypertensionObese, normotension

Participants are subjected to 5 days of low (90 mmol/day) and high (250 mmol/day) sodium intake in a randomized order before and 1 year after laparoscopic gastric bypass surgery.

ControlObese, hypertensionObese, normotension

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The cases are recruited from the Bariatric Clinics at Glostrup Hospital, Koege Hospital and The Private Hospital Hamlet. Controls are recruited through public advertisement

You may qualify if:

  • Caucasians fulfilling the criteria for laparoscopic gastric bypass.
  • participants with hypertension, defined as blood pressure \> 140/90 and/or use of antihypertensive medication and 12 participants without hypertension.
  • Body mass index 40-50 kg/m2
  • Caucasian.
  • No hypertension or use of antihypertensive medication.
  • Body mass index \< 30 kg/m2

You may not qualify if:

  • Pregnancy
  • Chronic obstructive pulmonary disease
  • Diabetes mellitus
  • Medical treatment with sibutramine.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Koege, Department of Clinical Physiology and Nuclear Medicine

Koege, DK-4600, Denmark

Location

Related Publications (1)

  • Bonfils PK, Taskiran M, Damgaard M, Goetze JP, Floyd AK, Funch-Jensen P, Kristiansen VB, Stockel M, Bouchelouche PN, Gadsboll N. Roux-en-Y gastric bypass alleviates hypertension and is associated with an increase in mid-regional pro-atrial natriuretic peptide in morbid obese patients. J Hypertens. 2015 Jun;33(6):1215-25. doi: 10.1097/HJH.0000000000000526.

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples: p-glucose, p-insulin, MR-proANP, hemoglobine, sodium, potassium, creatinine, albumine. Urine collections: u-sodium, u-potassium, u-creatinine

MeSH Terms

Conditions

ObesityHypertension

Interventions

Blood PressureAbsorptiometry, PhotonPlasma VolumeGlomerular Filtration RateBlood Specimen CollectionDiet

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Vital SignsPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisHemodynamicsCardiovascular Physiological PhenomenaCirculatory and Respiratory Physiological PhenomenaRadiographyDiagnostic ImagingDensitometryPhotometryChemistry Techniques, AnalyticalInvestigative TechniquesBlood VolumeBlood Physiological PhenomenaKidney Function TestsDiagnostic Techniques, UrologicalUrinary Tract Physiological PhenomenaReproductive and Urinary Physiological PhenomenaSpecimen HandlingClinical Laboratory TechniquesPuncturesSurgical Procedures, OperativeNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Peter K Bonfils, MD

    University Hospital Koege

    PRINCIPAL INVESTIGATOR
  • Morten Damgaard, MD, Ph.D.

    Hvidovre Hospital, Copenhagen

    STUDY DIRECTOR
  • Mustafa Taskiran, MD, Ph.D.

    University Hospital Koege

    STUDY DIRECTOR
  • Viggo B Kristiansen, MD

    Glostrup Hospital, Copenhagen

    STUDY DIRECTOR
  • Knud H Stokholm, MD

    University Hospital Koege

    STUDY DIRECTOR
  • Niels Gadsboll, MD, DMSc

    University Hospital Koege

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 19, 2009

First Posted

October 20, 2009

Study Start

November 1, 2009

Primary Completion

December 1, 2012

Study Completion

January 1, 2013

Last Updated

March 20, 2013

Record last verified: 2013-03

Locations